PVI
ORGO icon

Pura Vida Investments’s Organogenesis Holdings ORGO Stock Holding History

Pura Vida Investments’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-345,000
Closed -$3.19M – 272
2021
Q4 		$3.19M Buy
345,000
+60,500
+21% +$643K 0.12% 132
2021
Q3 		$4.05M Buy
+284,500
New +$4.42M 0.12% 159

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Pura Vida Investments's ORGO Position: Q4 2023 in Review

Pura Vida Investments sold out of Organogenesis Holdings (ORGO) in Q4 2023, closing a stake of 301,697 shares — an estimated $959K sold.

Pura Vida Investments first reported a position in ORGO in Q4 2020 and held it in 4 quarters. The position peaked at $27.5M in Q1 2021. 108 funds tracked by Wall St. Rank hold ORGO as of Q4 2023.

  • Pura Vida Investments reported no remaining Organogenesis Holdings position as of Q4 2023 after selling out during the quarter.
  • Pura Vida Investments sold 301,697 Organogenesis Holdings shares in Q4 2023, an estimated $959K.
  • Pura Vida Investments first reported a position in Organogenesis Holdings in Q4 2020 and held it in 4 quarters.
  • Pura Vida Investments's Organogenesis Holdings position peaked at $27.5M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2023.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.